Autoimmune hepatitis as the first manifestation of autoimmune polyendocrine syndrome type 1 in a 5-year-old girl

Autoimmune hepatitis is a chronic inflammatory liver disease of unknown etiology; the prevalence of juvenile autoimmune hepatitis is unknown. Autoimmune hepatitis occurs in 10–20% of patients with type 1 autoimmune polyendocrine syndrome, a rare (orphan) disease, which is characterized by a clinical triad in 70–100% of cases: chronic mucocutaneous candidiasis, hypopara thy roidismand adrenal insufficiency, as well as more 25 possible autoimmune endocrine and non-endocrine manifestations.

Thisstudy describes a case of a 5-year-old girl with autoimmune hepatitis as the first clinical manifestation of the disease. The symptoms of chronic mucocutaneous candidiasis enabled us to suggest and genetically confirm the diagnosis of autoimmune poly endocrine syndrome type 1 before the lesions of endocrine organs. The girl had nonsense mutations R257 * and p.Q94* of the AIRE gene in a compound heterozygous state. Later, there appeared another autoimmune disorder – common vitiligo.

Timelydiagnosisoftype1autoimmunepolyendocrinesyndromeinachildwiththefirstnon-endocrine autoimmune manifestation, initiation of therapy and further medical management made it possible to preventseve recomplications and improve the patient’s quality of life.

1. Mieli-Vergani G., Vergani D., Baumann U., Czubkowski P., Fischler B., Gupte G. et al. Diagnosis and Management of Pediatric Autoimmune Liver Disease: ESPGHAN Hepatology Committee Position Statement. JPGN 2018; 66(2): 345–360. DOI: 10.1097/MPG.0000000000001801

2. Federal clinical guidelines for medical management of autoimmune hepatitis in children. MH RF. Union of pediatricians of Russia. 2015. (in Russ.). URL: http://cr.rosminzdrav.ru/#!/recomend/ ссылка активна на 19.02.2021.

3. Volynets G.V., Khavkin A.I., Skvortsova T.A., Matkash V.V. Autoimmune Hepatitis in Children: The Current State of the Problem. Rossiiskii zhurnal gastroehnterologii, gepatologii, koloproktologii 2018; 28(5): 18–34. (in Russ.)] https://10.22416/1382-4376-2018-28-5-18-34

4. Di Giorgio A., Bravi M., Bonanomi E., Sonzogni A., Colledan M., D’Antiga L. et al. Fulminant hepatic failure of autoimmune etiology in children. J Pediatr Gastroenterol Nutr 2015; 60: 159–164. DOI: 10.1097/MPG.0000000000000593

5. Strokova T.V., SurkovA.G., BagaevaM.E., Zubovich A.I., Pavlovskaya E.V., Matinyan I.A. Variants of the manifestation of autoimmune hepatitis in children. Pediatriya. Zhurnal im. G.N. Sperans kogo 2018; 97(6): 8–13 (in Russ.)

6. Porta G., Carvalho E., Santos J.L., Gama J., Borges C.V., Sei xasR.B. et al. Autoimmune hepatitis in 828 Brazilian children and adolescents: clinical and laboratory findings, histological profile, treatments, and outcomes. J Pediatr (Rio J) 2019; 95: 419–427. DOI: 10.1016/j.jped.2018.04.007

7. Guo L., Zhou L., Zhang N., Deng B., Wang B. Extrahepatic Autoimmune Diseases in Patients with Autoimmune Liver Diseases: A Phenomenon Neglected by Gastroenterologists. Gastroenterol Res Pract 2017; 2017: 2376231. DOI: 10.1155/2017/2376231

8. VanGervenN.M.,deBoerY.S.,MulderC.J.,vanNieuwkerkC.M., BoumaG. Autoimmune hepatitis. World J Gastroenterol 2016; 22(19): 4651–4661. DOI: 10.3748/wjg.v22.i19.4651

9. Peterson P., Pitkänen J., Sillanpää N., Krohn K. Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED): a model disease to study molecular aspects of endocrine autoimmunity. Clin Exp Immunol 2004; 135: 348– 357. DOI: 10.1111/j.1365-2249.2004.02384.x

10. Orlova E.M., Sozaeva L.S., Kareva M.A., Oftedal B.E., Wolff A.S.B., Breivik L. et al. Expanding the Phenotypic and Genotypic Landscape Polyendocrine Syndrome Type 1. J Clin Endocrinol Metab 2017; 102(9): 3546–3556. DOI: 10.1210/jc.2017-00139

11. Kuzmenko N.B., Varlamova T.V., Mersiyanova I.V., Raikina E.V., Bobrynina V.O., Shcherbina A.Y. Molecular genetic diagnosis of primary immunodeficiency states (literature review and own clinical observations). Voprosy gematologii/onkologii i immunopatologii v pediatrii. 2016; 15(1): 10–16. (in Russ)

12. Ferre E.M., Rose S.R., RosenzweigS.D., Burbelo P.D., Romito K.R., Niemela J.E. et al. Redefined clinical features and diagnostic criteria in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. JCI Insight 2016; 1: e88782. DOI: 10.1172/jci.insight.88782

13. Bruserud Ø., Oftedal B.E., Landegren N., ErichsenM., Brat-land E., Lima K. et al. A longitudinal follow-up of Autoimmune polyendocrine syndrome type 1. J Clin Endocrinol Metab 2016; 101: 2975–2983. DOI: 10.1210/jc.2016-1821

14. Orlova E.M., Sozaeva L.S., Karmanov M.E., Breivik L., Husby E., Kareva M.A. New immunological methods for the diagnosis of autoimmune poly-endocrine syndrome of the 1st type (first experience in Russia). Problemy endokrinologii 2015; 5: 9–13. (in Russ.)] DOI: 10.14341/probl20156159-13

15. Husebye E.S., Gebre-Medhin G., Tuomi T., Perheentupa J., Landin-Olsson M., Gustafsson J., Rorsman F., Kämpe O. Autoantibodies against aromatic L-amino acid decarboxylase in autoimmune polyendocrine syndrome type I. J Clin Endocrinol Metab 1997; 82(1): 147-50. DOI: 10.1210/jcem.82.1.3647

16. Federal clinical guidelines (protocols) for the management of children with endocrine diseases. I.I. Dedov, V.A. Peterkova (eds.) Moscow: Praktika, 2014; 442. (in Russ.)